Related Experiment Video

Updated: Jul 3, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Carvedilol in hypertension treatment

Panagiotis C Stafylas1, Pantelis A Sarafidis

  • 11st Department of Medicine, AHEPA University Hospital, Aristotle University, Thessaloniki, Greece.

Vascular Health and Risk Management
|July 17, 2008
PubMed

Insights

Carvedilol, a unique beta-blocker, may offer cardiovascular protection for hypertension without adverse metabolic effects. It reduces blood pressure by decreasing vascular resistance, unlike older beta-blockers.

Area of Science:

  • Pharmacology
  • Cardiology
  • Internal Medicine

Background:

  • Beta-blockers are established hypertension treatments, but their cardiovascular benefits are debated.
  • Older beta-blockers like atenolol have shown controversial outcomes.
  • Heterogeneity exists within beta-blocker pharmacokinetics and pharmacodynamics.

Purpose of the Study:

  • To summarize carvedilol's distinct properties compared to conventional beta-blockers.
  • To examine carvedilol's potential role in hypertension treatment.
  • To evaluate carvedilol's cardioprotective, hemodynamic, and metabolic profile.

Main Methods:

  • Review of pharmacologic, hemodynamic, and metabolic data on carvedilol.
  • Comparison of carvedilol with traditional beta-blockers (e.g., atenolol, metoprolol).
  • Analysis of studies on carvedilol's effects on cardiovascular parameters and metabolic health.

Main Results:

  • Carvedilol, a vasodilating non-cardioselective beta-blocker, maintains cardiac output and reduces vascular resistance.
  • Unlike traditional beta-blockers, carvedilol has less impact on heart rate and avoids concerning hemodynamic and metabolic actions.
  • Studies indicate carvedilol has neutral or beneficial effects on glycemic control, insulin sensitivity, and lipid metabolism.

Conclusions:

  • Carvedilol presents a cardioprotective option for hypertension management.
  • Its favorable hemodynamic and metabolic profile distinguishes it from older beta-blockers.
  • Carvedilol may be suitable for hypertensive patients with metabolic syndrome or diabetes.

Keywords:
carvedilolhypertension treatmentβ-blockers

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...